Exploring the Effects of Strength Training on Depressive Symptoms and Cardiovascular Risk in Black Men
探索力量训练对黑人抑郁症状和心血管风险的影响
基本信息
- 批准号:9182593
- 负责人:
- 金额:$ 18.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-26 至 2018-07-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcuteAddressAerobicAffectAfrican AmericanAmerican Heart AssociationBlindedBlood PressureBody CompositionCardiovascular DiseasesCardiovascular systemCause of DeathCessation of lifeClinicalClinical TrialsCognitiveDataDepressed moodDepressive disorderDevelopmentDiagnosisExerciseFemaleFundingFutureHealthHealth behaviorHeart DiseasesIndividualInterventionInterviewInterviewerLinkLiteratureMasculineMeasuresMediator of activation proteinMental DepressionMethodsMinorityMoodsParticipantPatient Self-ReportPharmaceutical PreparationsPharmacological TreatmentPhysical ExercisePhysiologicalPreparationProceduresPsychiatric therapeutic procedurePsychotherapyPublic HealthRandomizedRandomized Clinical TrialsRandomized Controlled TrialsRecruitment ActivityReportingResearchRisk FactorsRisk ReductionSamplingSelf ConceptSeveritiesSiteSleepSmokerStrokeSurveysTechniquesTestingTraining ProgramsWaist-Hip RatioWeightWeight Liftingabstractingbaseblindblood lipidburden of illnesscardiovascular disorder riskcardiovascular healthcardiovascular risk factorcombatdepressive symptomsefficacy testingexercise programexperiencefollow-uphealth disparityimprovedinflammatory markerinnovationmale healthmeetingsmenmortalitypreferenceprimary outcomeprogramsprospectivepsychologicsecondary outcomesedentaryself esteemsocialsocial stigmastrength training
项目摘要
Project Summary/Abstract
Depression is severely undertreated in Black men. Significant reasons for this include that traditional
psychiatric treatments (i.e., psychotherapy and medication) are less acceptable to Black men, and that Black
men report significant stigma regarding seeking these treatments. Depression also has major health
consequences, including increased occurrence and worsening of cardiovascular disease (CVD), and even
CVD mortality. We propose to address gaps in the literature and advance the field of minority men’s health by
conducting the first randomized controlled trial testing the effects of strength training (i.e., weight lifting) on
depression and cardiovascular health in a sample of depressed Black men. A total of 50 self-identifying Black
men who meet a clinical level of depression will be randomized into a 12-week strength training (ST) program
or a 12-week contact control. Both groups will meet on-site twice per week during the 12-week program, and
follow-up assessments will occur at the end of the 12-weeks and at a 3-month follow-up. Blind to condition
research staff will conduct assessments at baseline, end-of-treatment, and 3-month follow-up. Qualitative
interviews will be conducted immediately after the 3-month follow-up to gather input on participants’
experiences and preferences. The primary outcome will be depression severity (measured by interview).
Secondary outcomes will be inflammatory markers and CVD indicators (e.g., blood lipids, blood pressure,
waist-to-hip ratio, body composition). The overall aim of this exploratory (R21) study is to establish the
feasibility, acceptability, and initial efficacy of strength training as an intervention for depression in Black men.
Specific aims are (1) To assess the feasibility and acceptability of recruitment, retention, assessment, and
intervention procedures among depressed Black men, (2) To obtain preliminary evidence of efficacy in
preparation for a future R01-supported randomized clinical trial, and (3) To explore potential mediators of the
effect of ST on depression, including physiological (i.e., sleep quality) and psychological (i.e., self-esteem,
acute changes in affect, enjoyment of exercise, physical self-concept) variables. The proposed research will
lay the groundwork for a larger efficacy study of ST for Black men that will be fully powered to detect changes
in both depression and CVD risk over long-term follow-up. Such a trial would be an initial step to combating
major health disparities regarding CVD and treatment for depression among Black men.
项目概要/摘要
黑人男性的抑郁症治疗严重不足,其重要原因包括传统观念。
黑人男性不太接受精神科治疗(即心理治疗和药物治疗),并且黑人
男性表示,寻求这些治疗方法会带来严重的耻辱。抑郁症也对健康有重大影响。
后果,包括心血管疾病(CVD)的发生率增加和恶化,甚至
我们建议通过以下方式解决文献空白并推进少数族裔男性健康领域的发展。
进行第一个随机对照试验,测试力量训练(即举重)对身体的影响
抑郁症黑人男性样本中的抑郁症和心血管健康 共有 50 名自我认同的黑人。
达到临床抑郁程度的男性将被随机分配参加为期 12 周的力量训练 (ST) 计划
或为期 12 周的接触控制。在为期 12 周的计划中,两个小组每周将在现场会面两次,并且
后续评估将在 12 周结束时和 3 个月的盲态随访中进行。
研究人员将在基线、治疗结束和 3 个月随访时进行评估。
3个月的随访后将立即进行访谈,以收集参与者的意见
主要结果是抑郁症的严重程度(通过访谈衡量)。
次要结果是炎症标志物和 CVD 指标(例如血脂、血压、
这项探索性 (R21) 研究的总体目标是建立
力量训练作为黑人男性抑郁症干预措施的可行性、可接受性和初步疗效。
具体目标是 (1) 评估招聘、保留、评估和培训的可行性和可接受性
抑郁黑人男性的干预程序,(2) 获得初步疗效证据
为未来 R01 支持的随机临床试验做准备,以及 (3) 探索潜在的介质
ST 对抑郁症的影响,包括生理(即睡眠质量)和心理(即自尊、
情感、运动享受、身体自我概念)变量的急剧变化。
为黑人男性进行更大规模的 ST 功效研究奠定基础,该研究将完全有能力检测变化
这样的试验将是对抗抑郁症和心血管疾病风险的第一步。
黑人男性在心血管疾病和抑郁症治疗方面的主要健康差异。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrew M Busch其他文献
Andrew M Busch的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrew M Busch', 18)}}的其他基金
Multisite feasibility of BA-HD: An integrated depression and behavioral risk factor reduction coaching program following acute coronary syndrome
BA-HD 的多地点可行性:急性冠脉综合征后的综合抑郁症和行为危险因素减少辅导计划
- 批准号:
10680636 - 财政年份:2023
- 资助金额:
$ 18.86万 - 项目类别:
Secondary Prevention Following Acute Coronary Syndrome Using Integrated Smoking Cessation and Mood Management
使用综合戒烟和情绪管理进行急性冠脉综合征的二级预防
- 批准号:
9284290 - 财政年份:2017
- 资助金额:
$ 18.86万 - 项目类别:
Secondary Prevention Following Acute Coronary Syndrome Using Integrated Smoking Cessation and Mood Management
使用综合戒烟和情绪管理进行急性冠脉综合征的二级预防
- 批准号:
10392843 - 财政年份:2017
- 资助金额:
$ 18.86万 - 项目类别:
Secondary Prevention Following Acute Coronary Syndrome Using Integrated Smoking Cessation and Mood Management
使用综合戒烟和情绪管理进行急性冠脉综合征的二级预防
- 批准号:
9994997 - 财政年份:2017
- 资助金额:
$ 18.86万 - 项目类别:
Exploring the Effects of Strength Training on Depressive Symptoms and Cardiovascular Risk in Black Men
探索力量训练对黑人抑郁症状和心血管风险的影响
- 批准号:
9357672 - 财政年份:2016
- 资助金额:
$ 18.86万 - 项目类别:
Integrated Smoking Cessation and Mood Management for ACS Patients
ACS 患者的综合戒烟和情绪管理
- 批准号:
9324458 - 财政年份:2016
- 资助金额:
$ 18.86万 - 项目类别:
Integrated Smoking Cessation and Mood Management for Cardiac Patients
心脏病患者的综合戒烟和情绪管理
- 批准号:
8258254 - 财政年份:2011
- 资助金额:
$ 18.86万 - 项目类别:
Integrated Smoking Cessation and Mood Management for Cardiac Patients
心脏病患者的综合戒烟和情绪管理
- 批准号:
8089834 - 财政年份:2011
- 资助金额:
$ 18.86万 - 项目类别:
Integrated Smoking Cessation and Mood Management for Cardiac Patients
心脏病患者的综合戒烟和情绪管理
- 批准号:
8449738 - 财政年份:2011
- 资助金额:
$ 18.86万 - 项目类别:
Integrated Smoking Cessation and Mood Management for Cardiac Patients
心脏病患者的综合戒烟和情绪管理
- 批准号:
8650313 - 财政年份:2011
- 资助金额:
$ 18.86万 - 项目类别:
相似国自然基金
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Tenascin-X对急性肾损伤血管内皮细胞的保护作用及机制研究
- 批准号:82300764
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
- 批准号:82370084
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
KIF5B调控隧道纳米管介导的线粒体转运对FLT3-ITD阳性急性髓系白血病的作用机制
- 批准号:82370175
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
PHF6突变通过相分离调控YTHDC2-m6A-SREBP2信号轴促进急性T淋巴细胞白血病发生发展的机制研究
- 批准号:82370165
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Climate Change Effects on Pregnancy via a Traditional Food
气候变化通过传统食物对怀孕的影响
- 批准号:
10822202 - 财政年份:2024
- 资助金额:
$ 18.86万 - 项目类别:
Determining medications associated with drug-induced pancreatic injury through novel pharmacoepidemiology techniques that assess causation
通过评估因果关系的新型药物流行病学技术确定与药物引起的胰腺损伤相关的药物
- 批准号:
10638247 - 财政年份:2023
- 资助金额:
$ 18.86万 - 项目类别:
TIER-PALLIATIVE CARE: A population-based care delivery model to match evolving patient needs and palliative care services for community-based patients with heart failure or cancer
分级姑息治疗:基于人群的护理提供模式,以满足不断变化的患者需求,并为社区心力衰竭或癌症患者提供姑息治疗服务
- 批准号:
10880994 - 财政年份:2023
- 资助金额:
$ 18.86万 - 项目类别:
Identification of gene variants mediating the behavioral and physiological response to THC
鉴定介导 THC 行为和生理反应的基因变异
- 批准号:
10660808 - 财政年份:2023
- 资助金额:
$ 18.86万 - 项目类别: